Literature DB >> 17565465

Chronic hepatitis C: viral clearance several months after discontinuation of therapy in two non-responders.

J Denis1, P E Rautou, B Lambare, S Herbert, V Auray-Cartier, T Asselah.   

Abstract

When hepatitis C virus (HCV) infection becomes chronic, spontaneous viral eradication is a rare event. We report two patients with chronic hepatitis C, non-responders to standard interferon alone. They were treated with Pegylated interferon plus ribavirin. At the end of therapy, HCV RNA was still detectable. Several months after stopping treatment, aminotransferase level normalized and HCV RNA became undetectable. No case of sustained viral response happening several months after therapy has been yet described. During long-term follow-up of non-responders, when a persistent normalization of aminotransferase level is observed after stopping treatment, viral clearance could be suspected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565465     DOI: 10.1007/s15010-007-6099-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Delayed viral clearance of chronic hepatitis C in patients after treatment failure.

Authors:  Su Hyun Cho; Sung Wook Lee; Seok Reyol Choi; Sang Young Han; Myung Hwan Roh; Jong Hoon Lee; Jin Seok Jang; Yang Hyun Baek; Su Young Kim
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

2.  Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b.

Authors:  Akira Sato; Toshiya Ishii; Kayo Adachi; Hideaki Takahashi; Fumiaki Sano; Nobuyuki Matsumoto
Journal:  Case Rep Gastroenterol       Date:  2016-08-09

3.  Hepatitis C virus clearance after discontinuation of pegylated interferon alpha-2a monotherapy in a child.

Authors:  Takeshi Endo; Koichi Ito; Tokio Sugiura; Kenji Goto
Journal:  Case Rep Med       Date:  2012-10-18

4.  Lower-Dose and Long-Term Intermittent Interferon Therapy for Hepatitis C Genotype 2a may be a Possibility.

Authors:  Yoshio Araki; Tomoyuki Tsujikawa; Hiroyuki Sugihara; Yoshihide Fujiyama; Takanori Hattori
Journal:  Int J Biomed Sci       Date:  2008-09

5.  Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents.

Authors:  Subhasish Baral; Rahul Roy; Narendra M Dixit
Journal:  Immunol Cell Biol       Date:  2018-06-05       Impact factor: 5.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.